Shokeen led Quality Function in senior management roles at Johnson and Johnson (Auris Health) in its Robotics and Digital Solutions franchise. She is also a Registered Microbiologist (American Society of Microbiology) and holds a Sterilization Specialist certificate in Ethylene oxide (AAMI). Shokeen holds a doctorate degree in biomedical science from the University of South Dakota. Shokeen will lead SS Innovations’ Product Lifecycle Management, Quality System Management, regulatory strategy, and international submissions.ĭr. Sonia Shokeen as Head of Quality and Regulatory Affairs. SSII added another important player to their C-suite recently with the appointment of Dr. Eke represents a significant hiring coup for SSII given his breadth and experience within the robotic surgery space. It is well known in the high tech/med tech world that the best assets wear “tennis shoes,” and may work for whomever they wish. That being said, his coming to work for SSII is a major vote of confidence for SSII’s prospects going forward. Eke is an experienced medical technology team leader who could work for virtually any med tech company with his outstanding resume. Eke also managed Clinical and Capital Sales for Intuitive Surgical in the UK and Europe. He served as an Independent Tele-Mentoring Expert for CE Medical & Omnitivity, Ltd and was Head of Commercial Europe for CMR Surgical. Eke previously served as Global Head of New Business at CMR Surgical, Ltd with a focus on early adopting users and identifying potential customer sites to foster continued company growth. Eke brings more than 30 years’ industry experience to the role, including time spent at Intuitive Surgical and CMR Surgical. Colin Eke has been hired as Senior Vice President of Global Business Development. SSII has been busy building out their C-suite team as they prepare for major growth with FDA and European approvals right around the corner, in 20, respectively. One reason: They have been unable to penetrate ISRG’s vise-grip lock on the highly lucrative robotic surgery business. Lastly, we will take a peek at three formerly high-flying robotic surgery companies that have fallen substantially. We also discuss ISRG’s recent quarterly call to examine potential opportunities for competitors. These developments should help SSII position itself for significant approvals in both the US and Europe in 20. But in this article, we discuss some recent developments that could help SS Innovations International ( SSII) challenge it, writes John McCamant, special to MoneyShow. The barriers to entry are significant and to date have severely limited competition. Sponsored Content - Intuitive Surgical ( ISRG) holds a near-monopoly on the robotic surgery market since its da Vinci robotic surgery platform was approved by the FDA over 20 years ago.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |